| Labatec Pharma SA - Cabazitaxel Labatec 45 mg/4.5 ml, solution à diluer pour perfusion |
| 69233 | | 01 | | Cabazitaxel Labatec 45 mg/4.5 ml | | solution à diluer pour perfusion | | L01CD04 | | Cabazitaxel | | 20.04.2023 | | |
|
| Composition |
| cabazitaxelum 45 mg, polysorbatum 80, ethanolum anhydricum 888.75 mg, macrogolum 300, acidum citricum, ad solutionem pro 4.5 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| | 45mg / 4.5ml |
| | | | Inactive agents | Dose |
|---|
| Citric Acid | | | Ethanol Anhydrate | 888.75mg / 4.5ml | | Macrogol | 300 | | Polysorbatum 80 | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | A | | Yes |
|
